Table 2.
Clinical information and pRb2 staining scores for the studied BL cases.
Case number | Age | Sex | Biopsy/tumour site | pRb2 TMA staining score* |
1 | 6 | F | Palate | 3 |
2 | 6 | F | Ovary | 3 |
3 | 7 | F | Buccal cavity | 3 |
4 | 7 | M | Gingiva | 3 |
5 | 5 | F | Gingiva | 3 |
6 | 6 | F | Ovary | 3 |
7 | 6 | F | Buccal cavity | 1 |
8 | 7 | F | Buccal cavity | 2 |
9 | 7 | F | Ovary | 3 |
10 | 8 | F | Ovary | 3 |
11 | 7 | M | Unknown | 3 |
12 | 6 | M | Gingiva | 3 |
13 | 4 | M | Unknown | 3 |
14 | 5 | M | Jaw | 3 |
15 | 9 | M | Abdomen | 3 |
16 | 9 | F | Abdomen | 1 |
17 | 7 | M | Gingiva | 3 |
18 | 7 | F | Kidney | 2 |
19 | 12 | F | Ovary | 2 |
20 | 4 | F | Gingiva | 3 |
21 | 4 | F | Gingiva | n.a. |
22 | 13 | M | Liver | 3 |
23 | 13 | F | Abdomen | 3 |
24 | 7 | M | Orbit | 3 |
25 | 5 | F | Ovary | 3 |
26 | 3 | F | Ovary | 1 |
27 | 3 | F | Ovary | 3 |
28 | 5 | F | Ovary | 3 |
29 | 5 | M | Orbit | 3 |
30 | n.a. | n.a. | Unknown | 3 |
31 | 12 | F | Abdomen | 3 |
32 | 12 | F | Gingiva | 3 |
33 | 5 | M | Jaw | 2 |
34 | 8 | F | Ovary | 2 |
35 | 6 | M | Abdomen | 3 |
36 | 8 | F | Jaw | 3 |
37 | 5 | M | Orbit | 1 |
38 | 5 | M | Gingiva | 2 |
39 | 8 | F | Ovary | 2 |
40 | 5 | F | Ovary | 1 |
41 | 5 | F | Jaw | 2 |
42 | 7 | F | Ovary | 2 |
43 | 6 | M | Gingiva | 3 |
44 | 7 | M | Gingiva | 3 |
45 | 5 | M | Testis | 1 |
46 | 8 | M | Gingiva | 1 |
47 | 8 | F | Unknown | 3 |
48 | 8 | M | Gingiva | 1 |
49 | 6 | F | Jaw | 3 |
50 | 7 | M | Jaw | 2 |
51 | 5 | M | Jaw | 2 |
* 1 = absent (0% of tumour cells staining); 2 = low (1-50% of tumour cells staining); 3 = high (>50% of tumour cells staining). Case numbers in bold indicate those cases from which biopsy tissues were used in the mutation analysis. n.a. = not available.